These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 16255027)

  • 61. GABA-immunoreactive starburst amacrine cells in pigmented and albino rats.
    Blaszczyk WM; Telkes I; Distler C
    Eur J Neurosci; 2004 Dec; 20(11):3195-8. PubMed ID: 15579175
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Reexamination of Dopaminergic Amacrine Cells in the Rabbit Retina: Confocal Analysis with Double- and Triple-labeling Immunohistochemistry.
    Lee JW; Lim MY; Park YS; Park SJ; Kim IB
    Exp Neurobiol; 2017 Dec; 26(6):329-338. PubMed ID: 29302200
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Loss of asymmetric spine synapses in prefrontal cortex of motor-asymptomatic, dopamine-depleted, cognitively impaired MPTP-treated monkeys.
    Elsworth JD; Leranth C; Redmond DE; Roth RH
    Int J Neuropsychopharmacol; 2013 May; 16(4):905-12. PubMed ID: 22947206
    [TBL] [Abstract][Full Text] [Related]  

  • 64. α-synuclein overexpression in the retina leads to vision impairment and degeneration of dopaminergic amacrine cells.
    Marrocco E; Indrieri A; Esposito F; Tarallo V; Carboncino A; Alvino FG; De Falco S; Franco B; De Risi M; De Leonibus E
    Sci Rep; 2020 Jun; 10(1):9619. PubMed ID: 32541823
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Functional neuroarchitecture of the retina: hypothesis on the dysfunction of retinal dopaminergic circuitry in Parkinson's disease.
    Nguyen-Legros J
    Surg Radiol Anat; 1988; 10(2):137-44. PubMed ID: 3135618
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Demonstration of dopaminergic amacrine cells in newborn cat retina with an improved immunocytochemical method].
    Wang HH
    Sheng Li Xue Bao; 1988 Oct; 40(5):523-7. PubMed ID: 3251365
    [No Abstract]   [Full Text] [Related]  

  • 67. Gestational lead exposure selectively decreases retinal dopamine amacrine cells and dopamine content in adult mice.
    Fox DA; Hamilton WR; Johnson JE; Xiao W; Chaney S; Mukherjee S; Miller DB; O'Callaghan JP
    Toxicol Appl Pharmacol; 2011 Nov; 256(3):258-67. PubMed ID: 21703292
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Structural and functional changes in the retina in Parkinson's disease.
    Alves JN; Westner BU; Højlund A; Weil RS; Dalal SS
    J Neurol Neurosurg Psychiatry; 2023 Jun; 94(6):448-456. PubMed ID: 36806480
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Dopaminergic modulation of visual sensitivity in man.
    Masson G; Mestre D; Blin O
    Fundam Clin Pharmacol; 1993; 7(8):449-63. PubMed ID: 8294083
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Treating the patient with Parkinson's disease.
    J Mich Dent Assoc; 2003 Nov; 85(11):20. PubMed ID: 14664211
    [No Abstract]   [Full Text] [Related]  

  • 71. [TREATMENT OF SEVERE PARKINSON'S SYNDROME WITH ORPHENADRINE WITH SPECIAL REFERENCE TO MENTAL ACTIVITY].
    BAUER H
    Med Klin; 1963 Sep; 58():1523-6. PubMed ID: 14054489
    [No Abstract]   [Full Text] [Related]  

  • 72. Differences in Retinal and Choroidal Microvasculature and Structure in Dementia With Lewy Bodies Compared With Normal Cognition.
    Joseph S; Robbins CB; Allen A; Haystead A; Hemesath A; Kundu A; Ma JP; Johnson KG; Agrawal R; Gunasan V; Stinnett SS; Grewal DS; Fekrat S
    J Vitreoretin Dis; 2024; 8(1):67-74. PubMed ID: 38223776
    [No Abstract]   [Full Text] [Related]  

  • 73. Starburst amacrine cells, involved in visual motion perception, loose their synaptic input from dopaminergic amacrine cells and degenerate in Parkinson's disease patients.
    Sánchez-Sáez X; Ortuño-Lizarán I; Sánchez-Castillo C; Lax P; Cuenca N
    Transl Neurodegener; 2023 Apr; 12(1):17. PubMed ID: 37013599
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Retinal Degeneration: A Window to Understand the Origin and Progression of Parkinson's Disease?
    Zhang Y; Zhang X; Yue Y; Tian T
    Front Neurosci; 2021; 15():799526. PubMed ID: 35185448
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Multimodal brain and retinal imaging of dopaminergic degeneration in Parkinson disease.
    Lee JY; Martin-Bastida A; Murueta-Goyena A; Gabilondo I; Cuenca N; Piccini P; Jeon B
    Nat Rev Neurol; 2022 Apr; 18(4):203-220. PubMed ID: 35177849
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Role of Microgliosis and NLRP3 Inflammasome in Parkinson's Disease Pathogenesis and Therapy.
    de Araújo FM; Cuenca-Bermejo L; Fernández-Villalba E; Costa SL; Silva VDA; Herrero MT
    Cell Mol Neurobiol; 2022 Jul; 42(5):1283-1300. PubMed ID: 33387119
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Dopamine, Alpha-Synuclein, and Mitochondrial Dysfunctions in Parkinsonian Eyes.
    Indrieri A; Pizzarelli R; Franco B; De Leonibus E
    Front Neurosci; 2020; 14():567129. PubMed ID: 33192254
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Dopaminergic Retinal Cell Loss and Visual Dysfunction in Parkinson Disease.
    Ortuño-Lizarán I; Sánchez-Sáez X; Lax P; Serrano GE; Beach TG; Adler CH; Cuenca N
    Ann Neurol; 2020 Nov; 88(5):893-906. PubMed ID: 32881029
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Parafoveal thinning of inner retina is associated with visual dysfunction in Lewy body diseases.
    Murueta-Goyena A; Del Pino R; Reyero P; Galdós M; Arana B; Lucas-Jiménez O; Acera M; Tijero B; Ibarretxe-Bilbao N; Ojeda N; Peña J; Cortés J; Gómez-Esteban JC; Gabilondo I
    Mov Disord; 2019 Sep; 34(9):1315-1324. PubMed ID: 31136022
    [TBL] [Abstract][Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.